JJ
| |
JOHNSON & JOHNSON13F | |
JOHNSON & JOHNSON | |
Last update 2025-05-07 | 20 Stocks (0 new) |
Value $342.00 Mil | Turnover 0 % |
JOHNSON & JOHNSON Top Holdings of 2025-03-31
View Full List
Ticker | | Company | Shares | Value ($1000) | Shares Change % | Weighting % | Trade Impact % | % of Shares outstanding | 3M Change % | YTD Change % | Market Cap $Mil | Industry |
---|---|---|---|---|---|---|---|---|---|---|---|---|
PTGX | Protagonist Therapeutics Inc | 2,449,183 | 118,442.5 | 0% | 34.650 | 0% | 3.950 | +9.78% | +32.25% | 3,164.2 | Biotechnology | |
CVRX | CVRx Inc | 4,103,430 | 50,184.9 | 0% | 14.680 | 0% | 15.750 | -46.37% | -48.07% | 171.6 | Medical Devices & Instruments | |
MGTX | MeiraGTx Holdings PLC | 6,641,064 | 45,026.4 | 0% | 13.170 | 0% | 8.310 | +22.51% | +23.32% | 603.5 | Biotechnology | |
LEGN | Legend Biotech Corp | 814,586 | 27,638.9 | 0% | 8.080 | 0% | 0.440 | +8.39% | +9.53% | 6,558.8 | Biotechnology | |
RAPP | Rapport Therapeutics Inc | 2,498,051 | 25,055.5 | 0% | 7.330 | 0% | 6.840 | +41.31% | -32.13% | 439.4 | Biotechnology | |
PRCT | PROCEPT BioRobotics Corp | 357,939 | 20,853.5 | 0% | 6.100 | 0% | 0.650 | +5.73% | -28.07% | 3,204.6 | Medical Devices & Instruments | |
NBTX | Nanobiotix SA | 5,623,816 | 20,133.3 | 0% | 5.890 | 0% | 11.860 | +44.08% | +69.69% | 230.8 | Biotechnology | |
CTNM | Contineum Therapeutics Inc | 1,979,173 | 13,814.6 | 0% | 4.040 | 0% | 7.650 | -36.70% | -73.52% | 100.4 | Biotechnology | |
XNCR | Xencor Inc | 748,062 | 7,959.4 | 0% | 2.330 | 0% | 1.050 | -5.61% | -63.36% | 599.3 | Biotechnology | |
ARWR | Arrowhead Pharmaceuticals Inc | 247,598 | 3,154.4 | 0% | 0.920 | 0% | 0.180 | +39.22% | -10.69% | 2,318.7 | Biotechnology |
JOHNSON & JOHNSON's Historical Top Holdings Breakdowns
JOHNSON & JOHNSON's Top Stock Picks
View Full List
Ticker | | Company | Date | Action | Impact % | Price Range | Price | Price Change from Avrg% | Comment | Current Shares | Share Change |
---|---|---|---|---|---|---|---|---|---|---|---|
LYEL | Lyell Immunopharma Inc | 2024-12-31 | New Buy New Buy | +0.14% | 11.9 ($19.73) 29.6 | $9.69 | -50.89% | New holding | 41,166 | 823,317 | |
PHGE | BiomX Inc | 2024-12-31 | Reduce Reduce | -0.02% | 0.49 ($0.75) 0.98 | $0.44 | -41.33% | Reduce -49.63% | 96,866 | -95,455 | |
CLSD | Clearside Biomedical Inc | 2024-12-31 | Sold Out Sold Out | -0.02% | 0.87 ($1.09) 1.58 | $0.81 | -25.48% | Sold Out | 0 | -82,481 | |
ALDX | Aldeyra Therapeutics Inc | 2024-09-30 | Sold Out Sold Out | -0.25% | 3.19 ($4.76) 6.32 | $4.30 | -9.66% | Sold Out | 0 | -299,669 | |
CLSD | Clearside Biomedical Inc | 2024-09-30 | New Buy New Buy | +0.02% | 0.93 ($1.14) 1.35 | $0.81 | -28.75% | New holding | 82,481 | 82,481 | |
KVUE | Kenvue Inc | 2024-06-30 | Sold Out Sold Out | -88.66% | 17.96 ($19.37) 21.23 | $21.05 | 8.67% | Sold Out | 0 | -182,329,550 | |
RAPP | Rapport Therapeutics Inc | 2024-06-30 | New Buy New Buy | +14.50% | 20.8 ($23.15) 26.19 | $12.04 | -47.99% | New holding | 2,498,051 | 2,498,051 | |
CTNM | Contineum Therapeutics Inc | 2024-06-30 | New Buy New Buy | +8.70% | 14.09 ($16.1) 20.8 | $3.88 | -75.90% | New holding | 1,979,173 | 1,979,173 | |
FUSN Unlock Delisted | Fusion Pharmaceuticals Inc | 2024-06-30 | Sold Out Sold Out | -1.77% | 21.24 ($21.41) 21.55 | $21.55 | 0.65% | Sold Out | 0 | -3,670,516 | |
SWAV Unlock Delisted | Shockwave Medical Inc | 2024-06-30 | Sold Out Sold Out | -1.23% | 319.93 ($329.09) 334.83 | $334.75 | 1.72% | Sold Out | 0 | -166,812 |
JOHNSON & JOHNSON Total Holding History ($B)
JOHNSON & JOHNSON's Asset Allocation
JOHNSON & JOHNSON Past Portfolios
Portfolio Date | Number of Stocks | New Stocks | Total Value ($Mil) | Q/Q Turnover |
---|---|---|---|---|
Top Ranked Articles
- 1
JOHNSON & JOHNSON's Hypothetical Growth since 2025-03-31
JOHNSON & JOHNSON's Yearly Returns
Year | Portfolio % | % | Excess Gain % |
---|
JOHNSON & JOHNSON's Holdings Heat Map
Size field:
JOHNSON & JOHNSON's Holdings Bubble Chart
JOHNSON & JOHNSON News
- 1